Skip to content
Products & Services · Total Revenues

Alliance revenues — Total Revenues

Bristol-Myers Squibb Alliance revenues — Total Revenues decreased by 18.3% to $94M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.8%, from $88M to $94M. Over 4 years (FY 2021 to FY 2025), Alliance revenues — Total Revenues shows a downward trend with a -11.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2020
Last reportedQ1 2026Apr 30, 2026
Rolls up toTotal Revenue

How to read this metric

An increase suggests successful commercialization of partnered assets or strong performance in co-promoted products, while a decrease may indicate expiring partnerships or underperformance of shared therapeutic portfolios.

Detailed definition

This metric represents the portion of total revenue generated through collaborative arrangements and partnerships with o...

Peer comparison

Most large-cap pharmaceutical firms report similar collaborative income under 'collaboration revenue' or 'alliance revenue' line items, which are standard for companies utilizing R&D partnerships.

Metric ID: bmy_segment_alliance_revenues_total_revenues

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$179M$179M$179M$188M$199M$173M$182M$144M$179M$138M$147M$134M$116M$105M$124M$88M$119M$125M$115M$94M
QoQ Change+0.0%+0.0%+5.0%+5.9%-13.1%+5.2%-20.9%+24.3%-22.9%+6.5%-8.8%-13.4%-9.5%+18.1%-29.0%+35.2%+5.0%-8.0%-18.3%
YoY Change+11.2%-3.4%+1.7%-23.4%-10.1%-20.2%-19.2%-6.9%-35.2%-23.9%-15.6%-34.3%+2.6%+19.0%-7.3%+6.8%
Range$88M$199M
CAGR-12.7%
Avg YoY Growth-9.9%
Median YoY Growth-8.7%
Current Streak2 quarters decline

Frequently Asked Questions

What is Bristol-Myers Squibb's alliance revenues — total revenues?
Bristol-Myers Squibb (BMY) reported alliance revenues — total revenues of $94M in Q1 2026.
How has Bristol-Myers Squibb's alliance revenues — total revenues changed year-over-year?
Bristol-Myers Squibb's alliance revenues — total revenues increased by 6.8% year-over-year, from $88M to $94M.
What is the long-term trend for Bristol-Myers Squibb's alliance revenues — total revenues?
Over 4 years (2021 to 2025), Bristol-Myers Squibb's alliance revenues — total revenues has grown at a -11.1% compound annual growth rate (CAGR), from $716M to $447M.
What does alliance revenues — total revenues mean?
Revenue earned from collaborative partnerships and profit-sharing agreements with other companies.